Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Lund

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Endocrinology|January 2, 1990
Plasminogen activator inhibitors: hormonally regulated serpinsP A Andreasen, B Georg, L R Lund, et al.
The EMBO Journal|November 1, 1991
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cellsL R Lund, J Rømer, E Rønne, et al.
The Journal of Investigative Dermatology|April 1, 1994
The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin woundsJ Rømer, L R Lund, J Eriksen, et al.
Placenta|March 29, 2000
Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimesterS F Bjørn, N Hastrup, J F Larsen, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 1, 1994
Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycleJ Skouv, P O Jensen, J Forchhammer, et al.
The Biochemical Journal|July 1, 1990
Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated ratsS N Freeman, P S Rennie, J Chao, et al.
The Journal of Experimental Medicine|April 3, 2001
Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activityB Lelongt, S Bengatta, M Delauche, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 1, 1988
Transforming growth factor-beta 1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell linesE Helseth, A Dalen, G Unsgaard, et al.
The American Journal of Pathology|October 1, 1994
The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancersC Pyke, J Rømer, P Kallunki, et al.
The American Journal of Pathology|January 1, 1991
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humansJ Grøndahl-Hansen, E Ralfkiaer, L T Kirkeby, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Endocrinology|January 2, 1990
Plasminogen activator inhibitors: hormonally regulated serpinsP A Andreasen, B Georg, L R Lund, et al.
The EMBO Journal|November 1, 1991
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cellsL R Lund, J Rømer, E Rønne, et al.
The Journal of Investigative Dermatology|April 1, 1994
The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin woundsJ Rømer, L R Lund, J Eriksen, et al.
Placenta|March 29, 2000
Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimesterS F Bjørn, N Hastrup, J F Larsen, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 1, 1994
Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycleJ Skouv, P O Jensen, J Forchhammer, et al.
The Biochemical Journal|July 1, 1990
Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated ratsS N Freeman, P S Rennie, J Chao, et al.
The Journal of Experimental Medicine|April 3, 2001
Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activityB Lelongt, S Bengatta, M Delauche, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 1, 1988
Transforming growth factor-beta 1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell linesE Helseth, A Dalen, G Unsgaard, et al.
The American Journal of Pathology|October 1, 1994
The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancersC Pyke, J Rømer, P Kallunki, et al.
The American Journal of Pathology|January 1, 1991
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humansJ Grøndahl-Hansen, E Ralfkiaer, L T Kirkeby, et al.
Pageof 7